UCREST 0005 Share Price
RM0.07
klse: UCrest Berhad
Stock Information
Board : Ace
Shariah : Shariah Compliant
Sector : Hospital or Centre Cloud Service Solution
Address: Lot 6.04 Level 6 KPMG Tower 8, First Avenue, Bandar Utama, 47800 Petaling Jaya, Selangor
Contact: +603-77289880
Website: https://www.ucrest.net/
Stock Background
Ucrest Berhad designs, develops, and markets IT products. The Company provides build-to-application (BTA) systems, chip designs (ASIC), board designs, and communications and multimedia systems.
Profit Analysis: UCREST 0005
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 22/07/26 | 4,264 | -617 | -617 |
| 24/04/26 | 3,594 | -795 | -795 |
| 28/01/26 | 2,789 | 569 | 569 |
| 29/10/25 | 3,310 | 1,112 | 1,112 |
| 29/07/25 | 4,662 | 1,664 | 1,664 |
| 29/04/25 | 6,515 | 1,653 | 1,653 |
| 22/01/25 | 4,617 | 1,393 | 1,393 |
| 29/10/24 | 2,646 | 457 | 457 |
| 30/07/24 | 4,574 | 814 | 814 |
| 26/04/24 | 5,795 | 1,927 | 1,927 |
| 30/01/24 | 4,128 | 1,245 | 1,245 |
| 26/10/23 | 1,992 | 940 | 940 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 14 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | 2,550 |
| Last 4 Quarter EPS (sen) | 0.34 |
| Last 4 Quarter PER | 18.96 |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | 0.00 |
| Net Tangible Assets (RM) | 600.00 |
| Goodwill (RM) | 4,860 |
| Cash (RM’000) | 9,310 |
| Debt (RM’000) | 353 |
| Total Debt (RM’000) | 5,700 |
| Net Assets (RM’000) | 41,970 |
| Current Ratio | 5.75 |
| Quick Ratio | 5.75 |
| Cash Ratio | 2.63 |
Technical
Technical Analysis
| MACD (26 vs 12) | -4.903 |
|---|---|
| Exponential Moving Average 5 | 0.062 |
| Exponential Moving Average 20 | 0.064 |
| Exponential Moving Average 90 | 0.066 |
| Relative Strength Index 14 | 0.67 |
| Stochastic %D 3 | 0.67 |
| Stochastic %K 14 | 0.67 |
6 reviews for UCREST 0005
Show all Most Helpful Highest Rating Lowest Rating
Only logged in customers who have purchased this product may leave a review.
Stock Profit Analysis
-
BNASTRA 7195 ★★★★★RM2.14 - PETRONM 3042 ★★★★★RM3.44
- CMSB 2852 ★★★★★RM1.00
- SUNREIT 5176 ★★★★★RM2.23
Salary Proof
BURSA MALAYSIA –
The group recorded profit before tax of RM0.814 million in the current financial year ended 31 May 2024 as compared to PBT of RM2 million in the preceeding financial year. The profit has reduced comparatively due to the increase spending in research and development in developing additional new capabilities for HealthierSG, development and productization of iMedic Optics, and customization of iMedic for the US market. Near future, The Company expects the US market to be one of the key revenue contributors in the near future. The effort invested in the Africa market has generated tremendouns amount interest in the past few months and there are several major projects that the Company is currently working on. The AI and IOMT technologies that the Company has developed continue to be the main traction of iMedic system as compared to all other players in the market.
BURSA MALAYSIA –
The Group’s revenue recorded as RM13.557 million for financial year ended 31 May 2023 with Q3 and Q4 recorded profit. The flagship product, iMedic contributed almost all the revenue and the remaining is attributed by customisation and maintenance services of the platform. iMedic will continue to be a significant revenue contributor in financial year ended 31 May 2024. However, the Group has also invested R&D of 3D and multi-Dimensional (“MD”) printing of healthcare, consumer, automotive and industrial products. The Group expects to see 3D or MD printing would be a significant revenue contributor.
The Star –
Stocks to watch for on Monday include UCrest, according to KF Apex Research. UCrest has signed a memorandum of understanding with Russian Direct Investment Fund (RDIF) to identify and manage contract manufacturers for the production of the Sputnik V vaccine for RDIF.
REMUNERATION STUDY –
In Financial Year End 2020, the directors’ remuneration was 0.28 million. It was slightly low compared to average in listed companies, considering the employees’ remuneration of 1.3 million and auditor’s remuneration of 125 thousands
The Edge –
Key Asic, together with UCrest Bhd, recently obtained a deal to provide internet of medical things (IoMT) technology to the medical sector. The companies announced in a joint statement that Key Asic’s MCard and UCrest’s iMedic would be bundled with ventilators manufactured by BMC Medical.
Investing Malaysia –
Average investing volume for UCrest Bhd in the past three months in stock market was 3199.9k lots
Investing Malaysia –
UCREST gets a score of 6.46 in our equity and assets quality test based on current share price of RM0.115
Investing Malaysia –
UCrest Bhd gets a score of 8.2 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 0005 in Bursa Malaysia did not propose any dividend for the past few years
Investing Malaysia –
UCREST is estimated to have a profit consensus of 2.11 millions, with an adjusted market capitalization of 51.04 millions
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 0.28 million. It was slightly low compared to average in listed companies, considering the employees’ remuneration of 1.1 million and auditor’s remuneration of 124 thousands